Physiological Changes With SPG Stimulation in Migraine Patients
NCT02510742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-08-02
Summary
Hypothesis:
Stimulation of the SPG at low frequencies (20 Hz)is believed to cause a physiological parasympathetic upregulation which increases VMCA, concentration and cephalic vessel diameter.
Conditions
- Chronic Migraine
Interventions
- DEVICE
-
Neurostimulation
Neurostimulation of sphenopalatine ganglion (SPG) of 20 Hz
- DEVICE
-
Sham stimulation
Sham stimulation of sphenopalatine ganglion (SPG) with amplitude=0
Sponsors & Collaborators
-
Danish Headache Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- Denmark
Study Locations
More Related Trials
-
Functional MRI (fMRI) in CGRP Induced Migraine
NCT00363532 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine
NCT05161871 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache
NCT01792817 ·Status: COMPLETED ·Phase: NA
-
Vagal Nerve Stimulation and Pain Frequency, Intensity in Chronic Migraine
NCT06191016 ·Status: RECRUITING ·Phase: NA
-
Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
NCT01667250 ·Status: COMPLETED ·Phase: NA
-
Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
NCT03156920 ·Status: COMPLETED ·Phase: NA
-
Non-pharmacological Treatments in Migraine.
NCT05596058 ·Status: TERMINATED ·Phase: NA
-
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
NCT01899040 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache
NCT03422796 ·Status: COMPLETED ·Phase: NA
-
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
NCT04231617 ·Status: COMPLETED ·Phase: NA
-
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
NCT00291395 ·Status: TERMINATED ·Phase: PHASE1
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
NCT00541736 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
NCT02486276 ·Status: COMPLETED ·Phase: NA
-
EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model
NCT00957983 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
NCT03592329 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine
NCT01653340 ·Status: COMPLETED ·Phase: NA
-
Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2
NCT00510172 ·Status: UNKNOWN ·Phase: NA
-
Saline Injections for Prophylactic Treatment of Chronic Migraine
NCT03919045 ·Status: TERMINATED ·Phase: PHASE4
-
RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine
NCT02122744 ·Status: WITHDRAWN ·Phase: NA
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
NCT05769348 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache
NCT00407992 ·Status: COMPLETED ·Phase: NA
-
Pathway CH-1 Long-Term Follow-Up
NCT01616511 ·Status: COMPLETED